Fujifilm sinking in $928 million to double drug manufacturing capacity at Hillerod Denmark facility
In a statement that sees Japan’s Fujifilm Holdings Corp stepping up its pivot towards healthcare, the Japanese giant said, it will spend $928 million to double its capacity at a drug manufacturing facility in Denmark, which it has pledged to use for producing COVID-19 treatments. Fujifilm Holdings Corp’s investment in Fujifilm Diosynth Biotechnologies will expand…









